Veracyte | VCYT - Debt

Stock Price
41.71
Daily Change
0.21 0.51%
Monthly
24.69%
Yearly
44.78%
Q2 Forecast
37.71

Veracyte reported $39.65M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Agenus USD 35.54M 2.34M Mar/2025
Agilent USD 3.35B 55M Sep/2025
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 312.77M 53.52M Dec/2025
Bruker USD 2.04B 34.4M Dec/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Illumina USD 2.55B 23M Dec/2025
Intrexon USD 0 13.82M Jun/2024
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
Laboratory Of America USD 6.53B 3.9M Dec/2025
Ligand Pharmaceuticals USD 451.49M 494K Dec/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Rigel Pharmaceuticals USD 59.69M 90K Jun/2024
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Siemens EUR 56.46B 450M Dec/2025
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Veracyte USD 39.65M 799K Dec/2025
Waters USD 1.49B 4.92M Dec/2025